tolterodine tartrate

Generic: tolterodine tartrate

Labeler: teva pharmaceuticals usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tolterodine tartrate
Generic Name tolterodine tartrate
Labeler teva pharmaceuticals usa, inc.
Dosage Form CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

tolterodine tartrate 4 mg/1

Manufacturer
Teva Pharmaceuticals USA, Inc.

Identifiers & Regulatory

Product NDC 0093-7164
Product ID 0093-7164_acae7de6-a2b9-4475-8b25-620c0fa55235
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA079141
Listing Expiration 2026-12-31
Marketing Start 2017-03-20

Pharmacologic Class

Classes
cholinergic muscarinic antagonist [epc] cholinergic muscarinic antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00937164
Hyphenated Format 0093-7164

Supplemental Identifiers

RxCUI
855182 855189
UPC
0300937164562 0300937163565
UNII
5T619TQR3R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tolterodine tartrate (source: ndc)
Generic Name tolterodine tartrate (source: ndc)
Application Number ANDA079141 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-7164-05)
  • 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-7164-56)
  • 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-7164-98)
source: ndc

Packages (3)

0093-7164-05 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-7164-05) 0093-7164-56 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-7164-56) 0093-7164-98 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-7164-98)

Ingredients (1)

tolterodine tartrate (4 mg/1)

Linked Drug Pages (1)

Tolterodine Tartrate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "acae7de6-a2b9-4475-8b25-620c0fa55235", "openfda": {"upc": ["0300937164562", "0300937163565"], "unii": ["5T619TQR3R"], "rxcui": ["855182", "855189"], "spl_set_id": ["973f98b5-4e8a-42d9-ac69-d4333d21c362"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-7164-05)", "package_ndc": "0093-7164-05", "marketing_start_date": "20170320"}, {"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-7164-56)", "package_ndc": "0093-7164-56", "marketing_start_date": "20170320"}, {"sample": false, "description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-7164-98)", "package_ndc": "0093-7164-98", "marketing_start_date": "20170320"}], "brand_name": "Tolterodine Tartrate", "product_id": "0093-7164_acae7de6-a2b9-4475-8b25-620c0fa55235", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "0093-7164", "generic_name": "Tolterodine Tartrate", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tolterodine Tartrate", "active_ingredients": [{"name": "TOLTERODINE TARTRATE", "strength": "4 mg/1"}], "application_number": "ANDA079141", "marketing_category": "ANDA", "marketing_start_date": "20170320", "listing_expiration_date": "20261231"}